Feed IH
IH

iHuman Inc. IH NYSE · Consumer defensive · China

$0.84 -2.21% -$0.02

Summary

46 / 100 · Bulios Score

What speaks for it

  • It holds more cash than debt: ¥796.4M against ¥8.33M.
  • The share price is below the Bulios Fair Price.
  • It bought back its own shares for ¥16.7M in the last fiscal year, 28% of its market value.

What to watch

  • Revenue fell by 6.4% a year over the last 3 years.
  • Out of every 100 CNY of revenue, only 3.2 CNY is left as net profit.
  • It passes only 3 of the 9 points of the Piotroski financial health test.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Bulios Fair Price
Undervalued Price today $0.84

By our assumptions the business is worth more than its shares cost today.

P/E today 2.5 63% higher
5-year average P/E 1.5
P/E today 2.5
Education & Training Services industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 2.5 CNY for 1 CNY of yearly profit. Over the last five years it was 1.5 CNY on average.

Valuation in detail

Is it growing?

It is shrinking

Revenue (CNY)

Diluted EPS (CNY)

Revenue grew by 8.7% a year over 5 years. Over the last 3 years it fell by 6.4% a year. Earnings per share fell by 4.8% a year over the last 3 years.

Growth in detail

Does it make money?

Poorly

Where 100 CNY of revenue goes

Net profit, industry median (Education & Training Services) 7.7 CNY

Out of every 100 CNY of revenue, 3.2 CNY is left as net profit.

Profitability in detail

Is it financially healthy?

Yes

It holds more cash than debt.

Financial health in detail

Does it pay a dividend?

High, safe
Yield
9.88%
Paid out of profit
25%

The company covers the payout with ease.

Dividends in detail

What do analysts expect?

Mildly positive

No analyst has published a price target.

100% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2021

By product

By region

The company reports no revenue by region.

Online Subscriptions brings in 74% of revenue.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy